G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 5,796 | 4,858 | 6,604 | 14,218 | 16,546 |
| Cost of Goods | 374 | 591 | 808 | 243 | N/A |
| Gross Profit | 5,422 | 4,267 | 5,796 | 13,975 | 16,546 |
| Operating Expenses | 43,382 | 46,002 | 44,796 | 39,753 | 40,634 |
| Operating Income | -37,586 | -41,144 | -38,192 | -25,535 | -24,088 |
| Interest Expense | 2,058 | 934 | 927 | 748 | 756 |
| Other Income | -130 | -69 | -83 | -21 | -24 |
| Pre-tax Income | -39,774 | -42,147 | -39,202 | -26,304 | -24,868 |
| Income Tax | 246 | 321 | 220 | 138 | 479 |
| Net Income Continuous | -40,020 | -42,468 | -39,422 | -26,442 | -25,347 |
| Net Income | $-40,020 | $-42,468 | $-39,422 | $-26,442 | $-25,347 |
| EPS Basic Total Ops | -0.95 | -1.00 | -0.94 | -0.65 | -0.66 |
| EPS Basic Continuous Ops | -0.95 | -1.00 | -0.94 | -0.65 | -0.66 |
| EPS Diluted Total Ops | -0.95 | -1.00 | -0.94 | -0.65 | -0.66 |
| EPS Diluted Continuous Ops | -0.95 | -1.00 | -0.94 | -0.65 | -0.66 |
| EBITDA(a) | $-37,041 | $-40,818 | $-37,865 | $-25,151 | $-23,704 |